Intellia Therapeutics
NTLA
143 hedge funds and large institutions have $669M invested in Intellia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 18 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 31
44% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 18
14% more capital invested
Capital invested by funds: $589M → $669M (+$80.7M)
5% more funds holding
Funds holding: 136 → 143 (+7)
3.1% more ownership
Funds ownership: 90.23% → 93.33% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
32% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $3.46M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$7.47M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$6.28M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.77M |
| 5 |
AG
Artal Group
Luxembourg
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$10.7M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.54M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.85M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.54M |
NTLA Hedge Fund Activity: Q4 2019 in Review
143 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q4 2019, worth a combined $669M — up 14% from $589M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new NTLA positions and 18 closed out — a net gain of 8 holders — while 45 added to existing stakes and 31 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $10.6M. The largest seller was Ontario Teachers' Pension Plan Board, exiting entirely with an estimated $10.7M sold.
- 143 institutional investors held Intellia Therapeutics (NTLA) as of Q4 2019, up from 136 in Q3 2019.
- Funds reported $669M of Intellia Therapeutics stock for Q4 2019, up 14% quarter-over-quarter.
- 26 funds opened new Intellia Therapeutics positions in Q4 2019 and 18 closed out, a net change of +8 holders.
- The largest Intellia Therapeutics buyer in Q4 2019 was Fidelity Investments, an estimated $10.6M added.
- The largest Intellia Therapeutics seller in Q4 2019 was Ontario Teachers' Pension Plan Board, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2019.